In a study by Chua DT [24] EGFR was shown to be expressed in 89% of nasopharyngeal carcinoma cases, and high EGFR expression is considered an independent prognostic factor for local control, non-recurrence and disease-related survival in stage III-IV NPC. Here, EGFR is linked to nasopharyngeal carcinoma.